Shuai Gao, PhD
About Shuai Gao, PhD
Dr. Gao received his PhD at University of Toledo working in Dr. Lirim
Shemshedini's lab. He was focusing on study of targeting soluble guanylyl
cyclase alpha-1 (sGCa1) using peptide in the prostate cancer. At Dr. Balk’s
lab, Dr. Gao researched the mechanism of repressive function of androgen
receptor (AR) in prostate cancer. It has been shown that AR suppresses the
expression of genes mediating DNA synthesis and cell cycle progression, and
this suppression is released in CRPC. Thus, it is crucial to block the
derepression during the CRPC treatment. Currently, Dr. Gao is completing
his postdoc under Dr. Changmeng Cai at the University of Massachusetts.
Publications
* authors contributed equally